Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

Fig. 2

Time to oncologic care by visit type A. Time from the date of referral documented in the electronic health record to the date of initial visit for all patients with new diagnoses with median values labeled with bars (median values in-person vs. telemedicine: 6.5 vs. 5 days). Referral dates were available for 168 of 185 patients new to the service line referred for new diagnoses (90.8%); 16 in-person visits and 1 telemedicine visits were missing a referral date. B. Time from index visit to treatment initiation across different treatment modalities. Median values labeled with bars (median values in-person vs. telemedicine: Surgery 16 vs. 22 days; Radiation 27.5 vs. 27.5 days; Systemic therapy 13 vs. 15 days)

Back to article page